Nov 3 (Reuters) - Kimberly-Clark ( KMB ) said on Monday
it will acquire Tylenol maker Kenvue ( KVUE ) in a deal valued
at about $48.7 billion.
(Reporting by Juveria Tabassum in Bengaluru; Editing by Arun
Koyyur)